Advertisement

Topics

NOXXON Pharma AG Company Profile

23:22 EDT 18th September 2018 | BioPortfolio

Berlin-based NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers® for the treatment of inflammatory diseases and hematological indications. NOXXON possesses a broad patent estate and has access to a readily scalable GMP production. In addition to its in-house programs, NOXXON discovers and develops Spiegelmers® in collaboration with partners from the pharmaceutical industry, including Eli Lilly and Hoffmann La-Roche. The business strategy of NOXXON is to broaden this range of collaborations through co-development and licensing agreements for the proprietary clinical and pre-clinical products. Currently the company has two compounds in clinical development.

Location

Max-Dohrn-Str. 8-10
Berlin
D-10589
Germany

Contact

Phone: 49 (0)30 / 72 62 47-0
Fax: 49 (0)30 / 72 62 47-225
Email: ebrimacombe@noxxon.net


News Articles [538 Associated News Articles listed on BioPortfolio]

Noxxon Pharma: Abkommen wird positiv bewertet

Die Analysten von First Berlin bestätigen die Kaufempfehlung für die Aktien von Noxxon Pharma. Das Kursziel für die Papiere von Noxxon sahen die Experten bisher bei 32,00 Euro. In der heutigen Stud...

Noxxon Pharma: DEWB-Beteiligung verhandelt Finanzierung neu

Das Biotechunternehmen Noxxon Pharma, das zu den Beteiligungen der DEWB gehört, hat seine Finanzierungsvereinbarung mit YA II PN, LTD neu verhandelt. Die Einigung kostet Noxxon zwar eine Million Eu.....

Noxxon Pharma: Rekrutierungsphase für NOX-A12 braucht mehr Zeit

Noxxon Pharma benötigt bei einer laufenden klinischen Studie mit dem Krebsmedikamentenkandidaten NOX-A12 zwar mehr Zeit bei der Rekrutierung der Patienten, rechnet aber weiterhin damit, im vierten .....

Noxxon Pharma: Kursziel sinkt - trotzdem Kaufempfehlung

Für die Aktie von Noxxon Pharma gibt es ein neues Kursziel von den Analysten bei First Berlin Equity Research. Statt bisher 28 Euro wird die Zielmarke nun bei 20 Euro an. Die Einstufung der Biotech.....

Aram Mangasarian explains the elegant mirror image technology of NOXXON Pharma for extracellular targets

In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Aram Mangasarian, CBO of NOXXON Pharma AG.

NOXXON Announces Convocation of the Annual General Meeting of Shareholders

Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX), the "Company", a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), hereby gives notice ...

Noxxon Announces Amendment to Loan Agreements

Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), anno...

Results of NOXXON Annual General Shareholders Meeting

Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME),annou...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Pharma APMs: Can the Industry Learn To Play Well With Others?

The alternative payment model (APM) is a nontraditional financial arrangement that rewards health care providers who deliver cost-effective, high-quality care. Now we are facing the possibility that p...

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [764 Associated Companies listed on BioPortfolio]

NOXXON Pharma AG

Berlin-based NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers® for the treatment of inflammatory diseases and hematological...

Noxxon Global Service Informática Ltda

Nil

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "NOXXON Pharma AG" on BioPortfolio

We have published hundreds of NOXXON Pharma AG news stories on BioPortfolio along with dozens of NOXXON Pharma AG Clinical Trials and PubMed Articles about NOXXON Pharma AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NOXXON Pharma AG Companies in our database. You can also find out about relevant NOXXON Pharma AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record